12,991 Shares in SIGA Technologies, Inc. (NASDAQ:SIGA) Purchased by AQR Capital Management LLC

AQR Capital Management LLC acquired a new position in SIGA Technologies, Inc. (NASDAQ:SIGA) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 12,991 shares of the company’s stock, valued at approximately $99,000.

Several other hedge funds have also recently bought and sold shares of SIGA. DekaBank Deutsche Girozentrale purchased a new stake in SIGA Technologies in the 2nd quarter worth about $40,000. Bayesian Capital Management LP purchased a new stake in SIGA Technologies in the 1st quarter worth about $97,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in SIGA Technologies by 38.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock worth $104,000 after acquiring an additional 3,829 shares in the last quarter. Lazard Asset Management LLC purchased a new stake in SIGA Technologies in the 1st quarter worth about $105,000. Finally, EntryPoint Capital LLC purchased a new stake in SIGA Technologies in the 1st quarter worth about $111,000. 55.40% of the stock is owned by hedge funds and other institutional investors.

SIGA Technologies Trading Down 2.1 %

Shares of SIGA Technologies stock opened at $6.92 on Friday. The stock has a 50-day moving average price of $8.08 and a 200 day moving average price of $8.26. The company has a market cap of $492.17 million, a P/E ratio of 6.29 and a beta of 0.90. SIGA Technologies, Inc. has a 1 year low of $4.26 and a 1 year high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.03 earnings per share for the quarter. SIGA Technologies had a return on equity of 51.40% and a net margin of 48.55%. The company had revenue of $21.81 million during the quarter. During the same period last year, the business earned ($0.04) earnings per share. On average, equities analysts forecast that SIGA Technologies, Inc. will post 1.01 earnings per share for the current fiscal year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.